Matthew macaluso (17 Ergebnisse)

Zustand: New. In English.

Paperback. Zustand: Very Good. 1. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New.

Paperback. Zustand: Brand New. 1st edition. 847 pages. 9.75x6.75x1.50 inches. In Stock.

Zustand: New. In English.

Zustand: New.

Taschenbuch. Zustand: Neu. Neuware - More than 130 medications are represented in this new Handbook of Practical Psychopharmacology. Intended as a quick-reference tool for clinicians, trainees, and other practitioners, it is rich in high-yield, evidence-based, and easily accessible information for commonly prescribed psychopharmacological agents, including antidepressants, antipsychotics, stimulants, mood stabilizers, and nutraceuticals/phytoceuticals.For each medication covered, readers will find concise, easily referenced information on - Indications- Contraindications- Dosing- Drug interactions- Clinical monitoring- Adverse effects Conveniently organized by drug class and indication, the handbook also features clinical pearls for each agent and class from experts and published literature in the field. Readers will benefit from evidence-based information on off-label prescribing, as well as from sections devoted to prescribing in special situations (e.g., pregnancy and lactation) and in specific populations (e.g., older adults and children/adolescents).As useful as a teaching tool and study guide as it is as an on-the-spot resource in outpatient, inpatient, and emergency settings, the Handbook of Practical Psychopharmacology is the busy practitioner's must-have companion.…

Zustand: New. In English.

Zustand: New. In English.

Hardcover. Zustand: Brand New. 1st edition. 442 pages. 9.25x6.25x1.00 inches. In Stock.

Zustand: New.

Taschenbuch. Zustand: Neu. Drug Development in Psychiatry | Matthew Macaluso (u. a.) | Taschenbuch | Advances in Neurobiology | viii | Englisch | 2024 | Springer | EAN 9783031210563 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The book reviews clinical trial methodology as it pertains to drug development in psychiatry. The reader will understand the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The reader will appreciate the history of drug development in psychiatry dating back to the era of serendipitous discovery and culminating in an era of new and highly focused targets. Readers will understand how drug development in psychiatry has changed and adapted with the discovery of novel mechanism of action drugs. Novel drugs and disease targets have changed the way developers and regulatory agencies think about clinical trial methodology.The book elucidates how biomarkers, genetics and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry. The book will be broken down into the following sections:a. Prior to the 1960s - Drug discovery by chance observationb. The last 50 years - refined targeting of CNS drugs without the discovery of mechanistically new drugsc. The future - the discovery and development of mechanistically new drugs. The examination of new targets, genetics and biomarkers.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The book reviews clinical trial methodology as it pertains to drug development in psychiatry. The reader will understand the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The reader will appreciate the history of drug development in psychiatry dating back to the era of serendipitous discovery and culminating in an era of new and highly focused targets. Readers will understand how drug development in psychiatry has changed and adapted with the discovery of novel mechanism of action drugs. Novel drugs and disease targets have changed the way developers and regulatory agencies think about clinical trial methodology.The book elucidates how biomarkers, genetics and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry. The book will be broken down into the following sections:a. Prior to the 1960s - Drug discovery by chance observationb. The last 50 years - refined targeting of CNS drugs without the discovery of mechanistically new drugsc. The future - the discovery and development of mechanistically new drugs. The examination of new targets, genetics and biomarkers.…

Hardcover. Zustand: Brand New. 467 pages. 9.25x6.10x1.26 inches. In Stock.

Zustand: New.